[
  {
    "ts": "2025-09-29T19:19:18+00:00",
    "headline": "Cytokinetics Stock Scores RS Rating Jump To 83",
    "summary": "Cytokinetics stock cleared that benchmark Monday, with a jump from 78 to 83 Monday.  IBD's proprietary RS Rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.  Cytokinetics stock has climbed more than 5% past a 47.90 entry in a first-stage consolidation, meaning it's now out of a proper buy range.",
    "url": "https://www.investors.com/news/cytokinetics-stock-scores-rs-ratingh-jump-to-83/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "7c85fc19-e3c5-32ac-8d17-03a88f6bbf08",
      "content": {
        "id": "7c85fc19-e3c5-32ac-8d17-03a88f6bbf08",
        "contentType": "STORY",
        "title": "Cytokinetics Stock Scores RS Rating Jump To 83",
        "description": "",
        "summary": "Cytokinetics stock cleared that benchmark Monday, with a jump from 78 to 83 Monday.  IBD's proprietary RS Rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.  Cytokinetics stock has climbed more than 5% past a 47.90 entry in a first-stage consolidation, meaning it's now out of a proper buy range.",
        "pubDate": "2025-09-29T19:19:18Z",
        "displayTime": "2025-09-29T19:19:18Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/7c85fc19-e3c5-32ac-8d17-03a88f6bbf08/cytokinetics-stock-scores-rs.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/37fad342ab4fe642cc2a7ae97fe0a35d",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tesunC_TmSzppxEtosEMlg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/37fad342ab4fe642cc2a7ae97fe0a35d.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dudhEZVVV_BhaxnKA.xQIg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/37fad342ab4fe642cc2a7ae97fe0a35d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/cytokinetics-stock-scores-rs-ratingh-jump-to-83/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "INCY"
            },
            {
              "symbol": "AUPH"
            },
            {
              "symbol": "HALO"
            },
            {
              "symbol": "CYTK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]